Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HGP0904, HGP0608, and HGP0816 in Hypertension and Dyslipidemia
NCT02899455Phase 3Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- Jul 2014
- Primary completion
- Jun 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of amlodipine, losartan, rosuvastatin in hypertension (HTN), dyslipidemia, sponsored by Hanmi Pharmaceutical. Started Jul 2014; status: completed.
02
Drugs
amlodipinelosartanrosuvastatin
03
Conditions
hypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on NCT02899455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02899455.